Becton, Dickinson and Company

NYSE:BDX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

💊 Pharmaceuticals

💉 Vaccines

Location

United States

Market Cap

USD 52.03 B

Share Price

USD 181.54

Avg Daily Volume

3,240,116

Change (1 day)

-0.46%

Change (1 year)

-24.90%

Change (YTD)

-19.98%

Becton, Dickinson and Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 3.30 B

Becton, Dickinson and Company Operating Cash Flow is USD 3.30 B for the Trailing 12 Months (TTM) ending March 31, 2025, a -12.28% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Becton, Dickinson and Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 3.76 B, a 79.18% change year over year.
Becton, Dickinson and Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 2.10 B, a -31.04% change year over year.
Becton, Dickinson and Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 3.04 B, a -39.89% change year over year.
Becton, Dickinson and Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 5.06 B, a 44.77% change year over year.